Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30

$9.79−0.33 (-3.26%)

Close on Nov 12, 2026Market cap $103.30MP/E –Yield –

Biodesix statistics

79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $103.30M; $1.69B
Enterprise Value: $122.03M; $2.21B
PS Ratio: 0.98; 1.54
PB Ratio: 11.91; 3.43

Enterprise valuationIndustry

EV / Sales: 1.16; 1.67

Share statisticsIndustry

Shares Outstanding: 11M; 59M
Shares Change (YoY): 31.3%; 2.40%
Shares Change (QoQ): 4.78%; 0.33%
Shares Held by Institutions: 41.4%; 83.6%

Short sellingIndustry

Short Interest: 210,018; –
Short Interest Change: 0.25%; -0.86%
Short % of Shares Outstanding: 1.99%; 4.21%
Days to Cover: 2.46; 4.41

Stock price statisticsIndustry

52-Week High: $31.97; –
52-Week Low: $5.26; –
20-Day Moving Average: $19.35; –
50-Day Moving Average: $24.23; –
200-Day Moving Average: $18.88; –
Average True Range (14): $2.42; –
Price Change (1 Week): -50.7%; -0.16%
Price Change (1 Month): -59.2%; 0.10%
Price Change (3 Months): -59.2%; 1.86%
Price Change (6 Months): -33.7%; 15.1%
Price Change (YTD): 44.0%; 5.96%
Price Change (1 Year): 17.4%; 8.30%
Price Change (3 Years): -62.3%; 20.9%
Price Change (5 Years): -93.7%; -13.8%
Average Volume (10 Days): 444,742; –
Average Volume (20 Days): 266,933; –
Average Volume (90 Days): 134,947; –
Relative Volume: 2.24; 0.77
Relative Strength Index (14): 23.8; 46.5
Volatility (1 Year): 121.3%; 63.0%
Beta (5 Years): 0.73; 0.77

MarginsIndustry

Operating Margin: -18.7%; -2.98%
Profit Margin: -25.7%; -2.01%
EBITDA Margin: -13.4%; 3.36%
FCF Margin: -18.1%; 2.98%

Returns on capitalIndustry

Return on Equity (ROE): -778.9%; 4.82%
Return on Assets (ROA): -29.6%; -3.06%
Return on Invested Capital (ROIC): -55.4%; 4.69%
Return on Capital Employed (ROCE): -24.7%; 0.40%

Financial positionIndustry

Current Ratio: 2.96; 1.41
Quick Ratio: 2.63; 0.99
Debt / Equity: 5.43; 0.69
Interest Coverage: -2.45; -0.63

GrowthIndustry

Revenue Growth (YoY): 31.2%; 9.63%
Revenue Growth (3Y CAGR): 32.3%; 11.3%
Revenue Growth (5Y CAGR): 14.2%; 12.6%

EfficiencyIndustry

Asset Turnover: 1.15; 0.81
Revenue Per Employee: $315.01K; $235.26K
Profits Per Employee: -$81.07K; -$5.12K
Employee Count: 334; 910
WACC: 9.53%; 8.16%

Income statement (TTM)Industry

Revenue: $105.21M; $638.13M
Operating Income: -$19.67M; -$675.66K
Net Income: -$27.08M; -$1.48M
EBITDA: -$14.10M; $1.43M
EPS (Diluted): -$2.76; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $28.41M; $98.48M
Total Debt: $47.15M; $246.10M
Net Cash (Debt): -$18.74M; $119.40K
Net Cash Per Share: -$1.78; $0.00
Equity (Book Value): $8.68M; $235.60M
Book Value Per Share: $0.82; $3.91
Tangible Book Value: -$8.89M; $1.59M
Working Capital: $27.89M; $30.06M

Cash flow (TTM)Industry

Operating Cash Flow: -$18.16M; $25.90M
Capital Expenditures: -$919.00K; -$15.83M
Free Cash Flow: -$19.07M; $18.83M
FCF Per Share: -$1.81; $0.36

Dividends and yieldsIndustry

Earnings Yield: -26.2%; 0.25%
FCF Yield: -18.5%; 2.58%
Buyback Yield: -31.7%; 0.99%
Shareholder Yield: -31.7%; 1.58%

Taxes and interestIndustry

Interest Expense: $8.02M; $7.37M
Income Tax: $0; $564.50K

Scores and fair valueIndustry

Altman Z-Score: -6.25; 2.24
Piotroski F-Score: 3; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	BDSX	S&P 500	Difference	BDSX per year	S&P 500 per year
1 month	-61.9%	-2.7%	−59.2 pts
3 months	-59.6%	-1.7%	−57.8 pts
Year to date	+44.0%	+11.9%	+32.1 pts
1 year	+23.1%	+12.0%	+11.2 pts
3 years	-59.2%	+78.2%	−137.4 pts	-25.8%	+21.2%
5 years	-93.7%	+73.2%	−167.0 pts	-42.5%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M BDSX shares were sold short on Oct 30, 2026, up 0.2% from the previous report. At recent volumes it would take 2.5 days to buy them back. Over the last 20 sessions, 50.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	210,018	+0.2%	85,505	2.5
Oct 15, 2026	209,504	+3.8%	89,325	2.4
Sep 30, 2026	201,849	-5.7%	109,841	1.8
Sep 15, 2026	214,006	-2.9%	64,993	3.3
Aug 31, 2026	220,383	+46.8%	166,058	1.3
Aug 14, 2026	150,085	-4.5%	94,816	1.6
Jul 31, 2026	157,187	-6.4%	58,674	2.7
Jul 15, 2026	167,970	+59.3%	76,533	2.2
Jun 30, 2026	105,427	+0.7%	125,490	1.0
Jun 15, 2026	104,666	-1.7%	39,919	2.6
May 29, 2026	106,463	-22.4%	46,923	2.3
May 15, 2026	137,196	-7.3%	101,631	1.4